Literature DB >> 21532463

Propofol enhances memory formation via an interaction with the endocannabinoid system.

Daniela Hauer1, Patrizia Ratano, Maria Morena, Sergio Scaccianoce, Isabel Briegel, Maura Palmery, Vincenzo Cuomo, Benno Roozendaal, Gustav Schelling, Patrizia Campolongo.   

Abstract

BACKGROUND: Propofol is associated with postoperative mood alterations and induces a higher incidence of dreaming compared with other general anesthetics. These effects might be mediated by propofol's inhibitory action on fatty acid amide hydrolase, the enzyme that degrades the endocannabinoid anandamide. Because propofol is also associated with a higher incidence of traumatic memories from perioperative awareness and intensive care unit treatment and the endocannabinoid system is involved in regulating memory consolidation of emotional experiences, the authors investigated whether propofol, at anesthetic doses, modulates memory consolidation via an activation of the endocannabinoid system.
METHODS: Male Sprague-Dawley rats were trained on an inhibitory avoidance task in which they received an inescapable foot shock upon entering the dark compartment of the apparatus. Drugs were administered intraperitoneally immediately or 30, 90, or 180 min after training. On the retention test 48 h later, the latency to reenter the dark compartment was recorded and taken as a measure of memory retention.
RESULTS: The anesthetic doses of propofol administered after training significantly increased latencies of 48-h inhibitory avoidance performance (483.4 ± 181.3, 432.89 ± 214.06, 300 and 350 mg/kg, respectively; mean ± SD) compared with the corresponding vehicle group (325.33 ± 221.22, mean ± SD), which is indicative of stronger memory consolidation in propofol treated rats. Administration of a nonimpairing dose of the cannabinoid receptor antagonist rimonabant blocked the memory enhancement induced by propofol (123.39 ± 133.10, mean ± SD). Delayed administration of propofol 90 and 180 min after training or immediate posttraining administration of the benzodiazepine midazolam or the barbiturate pentobarbital did not significantly alter retention.
CONCLUSIONS: These findings indicate that propofol, in contrast to other commonly used sedatives, enhances emotional memory consolidation when administered immediately after a stressful event by enhancing endocannabinoid signaling.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21532463     DOI: 10.1097/ALN.0b013e31821c120e

Source DB:  PubMed          Journal:  Anesthesiology        ISSN: 0003-3022            Impact factor:   7.892


  22 in total

Review 1.  Circulating Endocannabinoids: From Whence Do They Come and Where are They Going?

Authors:  Cecilia J Hillard
Journal:  Neuropsychopharmacology       Date:  2017-06-27       Impact factor: 7.853

2.  Endocannabinoid-mediated improvement on a test of aversive memory in a mouse model of fragile X syndrome.

Authors:  Mei Qin; Zachary Zeidler; Kristen Moulton; Leland Krych; Zengyan Xia; Carolyn B Smith
Journal:  Behav Brain Res       Date:  2015-05-12       Impact factor: 3.332

3.  Changes of blood endocannabinoids during anaesthesia: a special case for fatty acid amide hydrolase inhibition by propofol?

Authors:  Carina Jarzimski; Matthias Karst; Alexander A Zoerner; Christin Rakers; Marcus May; Maria T Suchy; Dimitrios Tsikas; Joachim K Krauss; Dirk Scheinichen; Jens Jordan; Stefan Engeli
Journal:  Br J Clin Pharmacol       Date:  2012-07       Impact factor: 4.335

4.  Endogenous cannabinoid release within prefrontal-limbic pathways affects memory consolidation of emotional training.

Authors:  Maria Morena; Benno Roozendaal; Viviana Trezza; Patrizia Ratano; Andrea Peloso; Daniela Hauer; Piray Atsak; Luigia Trabace; Vincenzo Cuomo; James L McGaugh; Gustav Schelling; Patrizia Campolongo
Journal:  Proc Natl Acad Sci U S A       Date:  2014-12-08       Impact factor: 11.205

5.  Endoplasmic reticulum stress is involved in the neuroprotective effect of propofol.

Authors:  Likui Wang; Weixiang Tang; Tongcui Jiang; Peng Lu; Yuanhai Li; Aimin Sun; Yujun Shen; Yin Chen; Haiping Wang; Zhijun Zong; Yiqiao Wang; Lijian Chen; Yuxian Shen
Journal:  Neurochem Res       Date:  2014-06-25       Impact factor: 3.996

6.  [Quality of results of therapy of acute respiratory failure : changes over a period of two decades].

Authors:  I Briegel; M Dolch; M Irlbeck; D Hauer; I Kaufmann; G Schelling
Journal:  Anaesthesist       Date:  2013-04-06       Impact factor: 1.041

7.  Enhancing Endocannabinoid Neurotransmission Augments The Efficacy of Extinction Training and Ameliorates Traumatic Stress-Induced Behavioral Alterations in Rats.

Authors:  Maria Morena; Andrea Berardi; Paola Colucci; Maura Palmery; Viviana Trezza; Matthew N Hill; Patrizia Campolongo
Journal:  Neuropsychopharmacology       Date:  2017-12-21       Impact factor: 7.853

8.  Chronic treatment with anesthetic propofol improves cognitive function and attenuates caspase activation in both aged and Alzheimer's disease transgenic mice.

Authors:  Haijun Shao; Yiying Zhang; Yuanlin Dong; Buwei Yu; Weiming Xia; Zhongcong Xie
Journal:  J Alzheimers Dis       Date:  2014       Impact factor: 4.472

9.  A genotype-specific, randomized controlled behavioral intervention to improve the neuroemotional outcome of cardiac surgery: study protocol for a randomized controlled trial.

Authors:  Daniela Hauer; Iris-Tatjana Kolassa; Rüdiger Paul Laubender; Ulrich Mansmann; Christian Hagl; Benno Roozendaal; Dominique J-F de Quervain; Gustav Schelling
Journal:  Trials       Date:  2013-04-01       Impact factor: 2.279

10.  The CB1 receptor antagonist AM251 impairs reconsolidation of pavlovian fear memory in the rat basolateral amygdala.

Authors:  Patrizia Ratano; Barry J Everitt; Amy L Milton
Journal:  Neuropsychopharmacology       Date:  2014-05-07       Impact factor: 7.853

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.